Pardes Biosciences, Inc.

CIK 1822711 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pardes Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Sep 18, 2023CT ORDER9999999997-23-004162
Sep 11, 202315-12G0001140361-23-043444
Aug 31, 202340001209191-23-047834
Aug 31, 2023EFFECT9999999995-23-002542
Aug 31, 20238-K0001140361-23-041917
Aug 31, 2023SC 14D9/A0001193125-23-225526
Aug 31, 2023EFFECT9999999995-23-002540
Aug 31, 2023SC 13E3/A0001193125-23-225530
Aug 31, 202340001209191-23-047832
Aug 31, 2023S-8 POS0001140361-23-041923
Aug 31, 2023POS AM0001140361-23-041918
Aug 31, 202340001209191-23-047813
Aug 31, 202340001209191-23-047836
Aug 31, 202340001209191-23-047825
Aug 31, 2023POS AM0001140361-23-041920
Aug 31, 202340001209191-23-047815
Aug 31, 2023SC 13E3/A0001140361-23-041914
Aug 31, 202325-NSE0001354457-23-000611
Aug 31, 2023SC 13D/A0001140361-23-042097
Aug 31, 202340001140361-23-042108
Aug 31, 202340001209191-23-047817
Aug 31, 202340001209191-23-047829
Aug 31, 202340001209191-23-047821
Aug 31, 202340001209191-23-047823
Aug 31, 202340001209191-23-047827